Comments to FDA: Probiotics Labeling Share page: Docket Number: FDA-2011-D-0376 Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics). Download Document Issues: Dietary Supplements Probiotics Other Issues Labeling Related Posts Press Releases and Statements CHPA Statement on Senate Confirmation of Dr. Makary as FDA Commissioner Mar 25, 2025 Press Releases and Statements CHPA Expresses Serious Disappointment and Concern for Consumers Over New Law in West Virginia Banning Certain Additives in Dietary Supplements Mar 25, 2025 Press Releases and Statements CHPA Comments on News of Dismissals & Layoffs at FDA Feb 18, 2025